yahoo_financeOriginal article
Jefferies says September lung data can offset AstraZeneca trial failure
Data ReadoutnegativeNegative
AI Analysis
Summary
AstraZeneca experienced a trial failure in a lung indication program, though analyst Jefferies suggests upcoming September lung data could help offset this setback.
Clinical Trial Data
Primary Endpoint
Not Met
Outcome Details
trial failure
Importance:5/10
Sentiment:
-0.30
lung cancerclinical trialdata readoutanalyst commentary
Related Companies
Read the original article
Published by yahoo_finance on July 22, 2026 2:50 PM